Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 350 of the 352 references it cites were found in a registry or an index.

Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies

Hewitt, Nicola J., Gómez Lechón, María José, Houston, J. Brian, Hallifax, David, Brown, Hayley S., Maurel, Patrick, Kenna, J. Gerald, Gustavsson, Lena, Lohmann, Christina, Skonberg, Christian, Guillouzo, Andre, Tuschl, Gregor, Li, Albert P., LeCluyse, Edward, Groothuis, Geny M. M., Hengstler, Jan G. · 2007 · Drug Metabolism Reviews

Abstract

This review brings you up-to-date with the hepatocyte research on: 1) in vitro-in vivo correlations of metabolism and clearance; 2) CYP enzyme induction, regulation, and cross-talk using human hepatocytes and hepatocyte-like cell lines; 3) the function and regulation of hepatic transporters and models used to elucidate their role in drug clearance; 4) mechanisms and examples of idiosyncratic and intrinsic hepatotoxicity; and 5) alternative cell systems to primary human hepatocytes. We also report pharmaceutical perspectives of these topics and compare methods and interpretations for the drug development process.

Overview

Integrity signals

Registry

Crossref · 10.1080/03602530601093489

Cites

350 of 350 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

1 retracted

Show all 352 references

Research works printed but not linked: 48

  1. Allen S. W., 2001, Drug Metab. Dispos., 29, 1074
  2. Andersson T. B., 2001, Drug Metab. Dispos., 29, 712
  3. Arand M., 2003, EXCLI J., 22, 22
  4. 10.1177/0091270003252519 · doi:10.1177/0091270003252519 · Paper page
  5. Bort R., 1996, Drug Metab. Dispos., 24, 834
  6. Bort R., 1996, Drug Metab. Dispos., 24, 969
  7. Brown H. S., 2006, Drug metab. Dispos., 200, 6
  8. Chauret N., 1998, Drug Metab. Dispos., 26, 1
  9. Code E. L., 1997, Drug Metab. Dispos., 25, 985
  10. Cui Y., 2001, Mol. Pharmacol., 60, 934, 10.1124/mol.60.5.934 · doi:10.1124/mol.60.5.934 · Paper page
  11. Curi-Pedrosa R., 1994, J. Pharmacol. Exp. Ther., 269, 384
  12. Donato M. T., 1995, Drug Metab. Disp., 23, 553
  13. Drew R., 1985, Agents Actions Suppl., 17, 127
  14. Drocourt L., 2001, Drug Metab. Dispos., 29, 1325
  15. Easterbrook J., 2001, Drug Metab. Dispos., 29, 141
  16. Elferink M. G., 2004, Physiol., 287, G1008
  17. Eneroth A., 2006, Drug Metab. Rev., 38, 61
  18. Gerbal-Chaloin S., 2001, Drug Metab. Dispos., 29, 242
  19. Goodwin B., 1999, Mol. Pharmacol., 56, 1329, 10.1124/mol.56.6.1329 · doi:10.1124/mol.56.6.1329 · Paper page
  20. Grillo M. P., 2001, Drug Metab. Dispos., 29, 1210
  21. Guengerich F. P, 1990, Basic Life Sci., 53, 381
  22. Hallifax D., 2006, Drug Metab. Dispos.
  23. 10.1517/17425255.1.1.61 · DOI
  24. Hewitt N. J., 2001, Drug Metab. Dispos., 29, 1042
  25. Hewitt N. J., Chem. Biol. Interact.
  26. Hickman D., 1998, Drug Metab. Dispos., 26, 207
  27. Hopwood J., 2004, Toxicology, 202, 103
  28. Klingmüller U., 2006, Systems Biology
  29. Koganti A., 2005, Drug Metab. Rev., 37, 212
  30. Kolars J. C., 1991, Hepatology, 13, 197
  31. Lieu Y. K., 1997, Am. J. Physiol., 272, E359
  32. 10.1016/j.cbi.2004.09.010 · DOI
  33. Liu X., 1999, Am. J. Physiol., 277, G12
  34. Lu A. Y. H, 1998, Drug Metab. Dispos., 26, 1217
  35. Nomeir A. A., 2001, Drug Metab. Dispos., 29, 748
  36. Nussler A., 2006, J. Hepatol., 200, 6
  37. Olinga P., 1998, Drug Metab. Dispos., 26, 5
  38. Parkinson A, 2001, Casserett and Doull's Toxicology. The Basic Science of Poisons 6th, 133
  39. Pascussi J. M., 2000, Mol. Pharmacol., 58, 361, 10.1124/mol.58.2.361 · doi:10.1124/mol.58.2.361 · Paper page
  40. Pascussi J. M., 2000, Mol. Pharmacol., 58, 1441, 10.1124/mol.58.6.1441 · doi:10.1124/mol.58.6.1441 · Paper page
  41. Ruegg C. E., 1997, In Vitro Technol., 10, 217
  42. Ruhnke M., 2005, Gastroenterology
  43. Shimada T., 1994, J. Pharmacol. Exp. Ther., 270, 414
  44. Stogniew M., 1982, Drug Metab. Dispos., 10, 609
  45. van Breemen R. B., 1985, Drug Metab. Dispos., 13, 318
  46. Wahlstrom A., 1989, Drug Metab. Dispos., 17, 218
  47. Wenz A., 1981, J. Biol. Chem., 256, 9809, 10.1016/S0021-9258(19)68697-7 · DOI
  48. Zimmerman H. J, 1994, Nonsteroidal Anti-Inflammatory Drugs: Mechanisms and Clinical Uses 2nd

Cited by

See all 744

Metadata

Authors
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., Guillouzo, A., Tuschl, G., Li, A. P., LeCluyse, E., Groothuis, G. M. M., & Hengstler, J. G.
Affiliations
  • University of Manchester (GB)
  • Inserm (FR)
  • AstraZeneca (Sweden) (SE)
  • Merck KGaA, Darmstadt (Germany) (DE)
  • University of Groningen (NL)
  • Leipzig University (DE)
Venue
Drug Metabolism Reviews
Published
2007-01
Volume
39
Issue
1
Pages
159-234
ISSN
  • 0360-2532 (ISSN-L)
  • 1097-9883
OpenAlex
W2171534546
Cited by
735
References
352
Citations by year
2026: 11 · 2025: 14 · 2024: 18 · 2023: 17 · 2022: 15 · 2021: 32 · 2020: 33 · 2019: 28 · 2018: 38 · 2017: 31 · 2016: 44 · 2015: 51 · 2014: 55 · 2013: 53 · 2012: 71
FWCI
6.82
Type
journal article
Language
en
Open access
closed
Locations
  • Drug Metabolism Reviews (publishedVersion)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion)
  • Research Explorer (The University of Manchester) (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
Keywords
primary human hepatocytes, drug metabolism, drug transporters, drug clearance, in vitro-in vivo correlation, idiosyncratic hepatotoxicity, drug development
MeSH terms
Animals, Carrier Proteins, Cytochrome P-450 Enzyme System, Pharmaceutical Preparations, Humans, Liver Diseases, Metabolic Clearance Rate, Models, Biological, Xenobiotics, Hepatocytes, Chemical and Drug Induced Liver Injury, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. https://app.cochat.ai/papers/10.1080/03602530601093489
The paper
Hewitt, N. J., Gómez Lechón, M. J., Houston, J. B., Hallifax, D., Brown, H. S., Maurel, P., Kenna, J. G., Gustavsson, L., Lohmann, C., Skonberg, C., Guillouzo, A., Tuschl, G., Li, A. P., LeCluyse, E., Groothuis, G. M. M., & Hengstler, J. G. (2007). Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies. Drug Metabolism Reviews. https://doi.org/10.1080/03602530601093489

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.